Clinical Trial Update: Circulating Tumor DNA in Surgical Lung Cancer Patients

View source ↗

Summary

This clinical trial update describes research on circulating tumor DNA in patients undergoing surgery for lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Shenzhen Gene Health Bio Tech Co., Ltd. | Conditions: Lung Neoplasms | Status: UNKNOWN